← FDA Drug Approvals (Drugs@FDA)

NUMBRINO

NDA · New Drug Application · Sponsor: OMNIVIUM PHARMS · Approved 2020-01-10

Drug application

FDA Application #

NDA209575

Application type

New Drug Application

Brand name

NUMBRINO

Generic name

COCAINE HYDROCHLORIDE NASAL

Active ingredients

COCAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

NASAL

Marketing status

Prescription

Sponsor

OMNIVIUM PHARMS

Manufacturer

OMNIVIUM PHARMACEUTICALS LLC.

First approval

2020-01-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown